(1) Finch J, Arenas R, Baran R. Fungal melanonychia. J Am Acad Dermatol. 2012 May; 66(5): 830–41.
(2) Midgley G, Moore Mk. Onychomycosis. Rev Iberoam Micol 1998; 15: 113-7.
(3) Singal A, Khanna D. Onychomycosis: Diagnosis and management. Indian J Dermatol Venereol Leprol. 2011 Dec; 77(6): 659–72.
(4) Grover C, Khurana A. An update on treatment of onychomycosis. Mycoses. 2012; 55: 541-51.
(5) Elewski BE. Onychomycosis: pathogenesis, diagnosis and management. Clin Microbiol Rev 1998; 11(3): 415-29.
(6) Moreno G, Arenas R. Other fungi causing onychomycosis. Clin Dermatol. 2010 Mar 4; 28(2): 160–3.
(7) Baudraz-Rosselet F, Rakosi T, Wili PB, Kenzelmann R. Treatment of onychomycosis with terbinafine. Br J Dermatol. 1992 Feb; 126 Suppl 39: 40–6.
(8) Shemer A. Update: medical treatment of onychomycosis. Dermatol Ther. 2012 Dec; 25(6): 582–93.
(9) Gupta AK, Paquet M, Simpson F, Tavakkol A. Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta-analysis of efficacy for continuous and intermittent regimens. J Eur Acad Dermatol Venereol. 2013 Mar; 27(3): 267–72.
(10) Lujan C. Ageusia por terbinafina; reporte de un caso. Dermatología Peruana 2002; 12: 218-19.
(11) Lombardo M, Cerati M, Pazzaglia A. Acute generalized exanthematous pustulosis induced by terbinafine. J Am Acad Dermatol. 2003 Jul; 49(1): 158–9.
(12) Díaz MC, Díaz P, Espinoza J, Carrillo AJ. [Evaluation of the in vitro susceptibility pattern of clinical isolates of Trichophyton mentagrophytes and Trichophyton rubrum in Santiago, Chile]. Rev Iberoam Micol. 2015 Jun; 32(2): 83–7.